SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response and its evasion by emerging viral variants and variant of concern (VOC) are unknown, but critical to understand reinfection risk and breakthrough infection following vaccination. Antibody immunoreactivi...

Full description

Bibliographic Details
Main Authors: Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, David Ross Darley, Deepti Pilli, Daniele Vitale, Vera Merheb, Fiona X Z Lee, Philip Cunningham, Gregory J Walker, Christina Fichter, David A Brown, William D Rawlinson, Sonia R Isaacs, Vennila Mathivanan, Markus Hoffmann, Stefan Pöhlman, Ohan Mazigi, Daniel Christ, Dominic E Dwyer, Rebecca J Rockett, Vitali Sintchenko, Veronica C Hoad, David O Irving, Gregory J Dore, Iain B Gosbell, Anthony D Kelleher, Gail V Matthews, Fabienne Brilot, Stuart G Turville
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-07-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003656

Internet

https://doi.org/10.1371/journal.pmed.1003656

Similar Items